Oxford Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Oxford Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26,706	Closed	-$77K	–	1703
2019 Q2	$77K	Buy	+26,706	New	+$45.9K	﹤0.01%	1623
2018 Q3	–	Sell	-101,688	Closed	-$623K	–	1685
2018 Q2	$623K	Sell	101,688 -20,181	-17%	-$142K	0.01%	1256
2018 Q1	$888K	Sell	121,869 -239,049	-66%	-$2.1M	0.02%	990
2017 Q4	$2.97M	Buy	360,918 +71,717	+25%	+$673K	0.06%	384
2017 Q3	$2.94M	Sell	289,201 -45,680	-14%	-$436K	0.06%	420
2017 Q2	$3.69M	Buy	334,881 +129,044	+63%	+$1.3M	0.07%	290
2017 Q1	$1.99M	Sell	205,837 -38,767	-16%	-$388K	0.05%	481
2016 Q4	$2.54M	Sell	244,604 -42,945	-15%	-$472K	0.09%	252
2016 Q3	$3.57M	Sell	287,549 -356	-0.1%	-$4.65K	0.11%	231
2016 Q2	$3.09M	Buy	287,905 +126,791	+79%	+$1.35M	0.1%	266
2016 Q1	$1.78M	Buy	+161,114	New	+$1.6M	0.05%	396
2015 Q4	–	Sell	-23,950	Closed	-$391K	–	874
2015 Q3	$391K	Buy	+23,950	New	+$527K	0.01%	524
2015 Q2	–	Sell	-39,413	Closed	-$709K	–	661
2015 Q1	$709K	Buy	+39,413	New	+$617K	0.02%	507
2014 Q2	–	Sell	-74,053	Closed	-$992K	–	691
2014 Q1	$992K	Buy	+74,053	New	+$794K	0.03%	457
2013 Q3	–	Sell	-12,089	Closed	-$74K	–	792
2013 Q2	$74K	Buy	+12,089	New	+$62.4K	﹤0.01%	834

Other funds holding AVDL

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Oxford Asset Management's AVDL Position: Q3 2019 in Review

Oxford Asset Management sold out of Avadel Pharmaceuticals (AVDL) in Q3 2019, closing a stake of 26,706 shares — an estimated $77K sold.

Oxford Asset Management first reported a position in AVDL in Q2 2013 and held it in 15 quarters. The position peaked at $3.69M in Q2 2017. 44 funds tracked by Wall St. Rank hold AVDL as of Q3 2019.

Oxford Asset Management reported no remaining Avadel Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 26,706 Avadel Pharmaceuticals shares in Q3 2019, an estimated $77K.
Oxford Asset Management first reported a position in Avadel Pharmaceuticals in Q2 2013 and held it in 15 quarters.
Oxford Asset Management's Avadel Pharmaceuticals position peaked at $3.69M in Q2 2017.
44 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.